Watson Lyn, Bialocerkowski Andrea, Dalziel Rodney, Balster Simon, Burke Frank, Finch Caroline
Lifecare, Prahran Sports Medicine Centre, Level 1, 316 Malvern Road, Prahran, Victoria 3181, Australia.
Br J Sports Med. 2007 Mar;41(3):167-73. doi: 10.1136/bjsm.2006.028431. Epub 2006 Dec 18.
To describe and compare the medium to long-term effectiveness of hydrodilatation and post-hydrodilatation physiotherapy in patients with primary and secondary glenohumeral joint contracture associated with rotator cuff pathology.
Patients with primary and secondary glenohumeral contractures associated with rotator cuff pathology were recruited into a 2-year study. They all underwent hydrodilatation, followed by a structured physiotherapy programme. Patients were assessed at baseline, 3 days, 1 week, 3 months, 1 year and 2 years after hydrodilatation with primary outcome measures (Shoulder Pain and Disability Index, Shoulder Disability Index and percentage rating of "normal" function; SD%) and secondary outcome measures (range of shoulder abduction, external rotation and hand behind back). Comparisons in recovery were made between the primary and secondary glenohumeral contracture groups at all timeframes and for all outcome measures.
A total of 53 patients (23 with primary and 30 with secondary glenohumeral contractures) were recruited into the study. At the 2-year follow-up, 12 patients dropped out from the study. At baseline, the two contracture groups were similar with respect to their demographic and physical characteristics. The two groups of patients recovered in a similar fashion over the 2-year follow-up period. A significant improvement was observed in all outcomes measures over this period (p<0.01), so that both function and range of movement increased. The rate of improvement was dependent on the outcome measure that was used.
Hydrodilatation and physiotherapy increase shoulder motion in individuals with primary and secondary glenohumeral joint contracture associated with rotator cuff pathology. This benefit continues to improve or is maintained in the long term, up to 2 years after hydrodilatation.
描述并比较液压扩张术及液压扩张术后物理治疗对伴有肩袖病变的原发性和继发性盂肱关节挛缩患者的中长期疗效。
将伴有肩袖病变的原发性和继发性盂肱关节挛缩患者纳入一项为期2年的研究。他们均接受了液压扩张术,随后进行结构化物理治疗方案。在液压扩张术后的基线、3天、1周、3个月、1年和2年对患者进行评估,主要结局指标包括(肩痛和功能障碍指数、肩部功能障碍指数以及“正常”功能的百分比评定;SD%),次要结局指标包括(肩部外展、外旋和手放于背后的活动范围)。在所有时间点及所有结局指标方面,对原发性和继发性盂肱关节挛缩组的恢复情况进行比较。
共有53例患者(23例原发性盂肱关节挛缩患者和30例继发性盂肱关节挛缩患者)被纳入研究。在2年随访时,有12例患者退出研究。在基线时,两个挛缩组在人口统计学和身体特征方面相似。两组患者在2年随访期内以相似的方式恢复。在此期间,所有结局指标均观察到显著改善(p<0.01),因此功能和活动范围均增加。改善率取决于所使用的结局指标。
液压扩张术和物理治疗可增加伴有肩袖病变的原发性和继发性盂肱关节挛缩患者的肩部活动度。这种益处会持续改善或在长期内维持,直至液压扩张术后2年。